Novus launches Abnova MaxPab Antibodies

MaxPab® is a new collection of polyclonal antibodies generated from annotated, sequence verified full-length proteins. Each MaxPab® antibody is validated with a full-length human protein expressed from a mammalian transfected lysate, demonstrating high reactivity, sensitivity and specificity. In addition, MaxPab® antibody has the ability to recognize both linear and conformational protein epitopes for maximum antibody performance! Novus Biologicals' is Abnova's North American distributor of these exciting new research tools.

Release Date: 
Monday, October 8, 2007 - 06:00